CANO HEALTH INC (CANO)

US13781Y2028 - Common Stock

2.3  -0.05 (-2.13%)

Premarket: 1.17 -1.13 (-49.13%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
831.6M
130.11%		1.609B
93.53%		2.739B
70.18%		3.2B
16.84%		2.847B
-11.03%		2.959B
3.93%		2.996B
1.25%		3.06B
2.14%		3.118B
1.90%		3.175B
1.83%		3.23B
1.73%
EBITDA
YoY % growth
18.3M
735.42%		-85.76M
-568.63%		-18.16M
78.82%		-251.083M
-1,282.61%		-10.2M
95.94%		90.772M
989.92%		175.44M
93.28%		236.64M
34.88%		257.04M
8.62%		278.46M
8.33%		300.9M
8.06%
EBIT
YoY % growth
-200K
97.94%		-135.2M
-67,500.00%		-108.8M
19.53%		-465.12M
-327.50%		-53.683M
88.46%		18.737M
134.90%		108.12M
477.04%		171.36M
58.49%		189.72M
10.71%		209.1M
10.22%		228.48M
9.27%
Operating Margin
-0.02%-8.40%-3.97%-14.54%-1.89%0.63%3.61%5.60%6.08%6.59%7.07%
EPS
YoY % growth
N/AN/A12.90
220.45%		-165.61
-1,383.78%		-38.06
77.02%		-17.77
53.32%		N/AN/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-18.30
-146.92%		-13.33
-11.10%		-8.48
83.37%		-11.21
87.79%		-6.28
65.66%		-6.07
54.48%		-6.25
26.28%		-4.41
60.71%		-5.11
18.67%
Revenue
Q2Q % growth		735.36M
8.08%		755.15M
-12.89%		706.31M
-7.88%		726.1M
-7.87%		707.6M
-3.78%		800.42M
5.99%		720.76M
2.05%		767.47M
5.70%		697.69M
-1.40%
EBITDA
Q2Q % growth		-39.44M
-177.27%		-6.712M
45.35%		-7.752M
95.94%		10.96M
134.59%		14.239M
136.10%		19.237M
386.62%		15.157M
295.52%		25.102M
129.03%		18.972M
33.24%
EBIT
Q2Q % growth		-57.35M
-44.82%		-24.449M
38.10%		-3.29M
98.66%		-20.155M
82.15%		-5.681M
90.09%		-775.2K
96.83%		-2.856M
13.18%		5.916M
129.35%		1.53M
126.93%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 -91.87
-299.43%		-18.78-73.09-389.24%
Q2 2023
Q2Q % growth		 -51.00
-1,600.00%		-11.99-39.02-325.53%
Q1 2023
Q2Q % growth		 -12.00
-11,900.00%		-12.430.433.48%
Q4 2022
Q2Q % growth		 39.00 -12.8951.89402.66%
Q3 2022
Q2Q % growth		 -23.00
-25,455.56%		-4.84-18.16-375.42%
Q2 2022
Q2Q % growth		 -3.00
-30,100.00%		-5.472.4745.20%
Q1 2022
Q2Q % growth		 -0.10 -6.706.6098.51%
Q4 2021
Q2Q % growth		 0.00 -0.020.02100.00%
Q3 2021
Q2Q % growth		 -0.09 -0.01-0.08-1,197.58%
Q2 2021
Q2Q % growth		 0.01 -0.010.02198.04%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 788.1M
18.51%		786.42M1.68M0.21%
Q2 2023
Q2Q % growth		 766.7M
11.21%		845M-78.3M-9.27%
Q1 2023
Q2Q % growth		 866.9M
23.09%		823.25M43.65M5.30%
Q4 2022
Q2Q % growth		 680.4M
66.24%		667.62M12.78M1.91%
Q3 2022
Q2Q % growth		 665M
33.29%		732.29M-67.29M-9.19%
Q2 2022
Q2Q % growth		 689.4M
100.64%		726.87M-37.47M-5.15%
Q1 2022
Q2Q % growth		 704.3M
156.48%		668.6M35.7M5.34%
Q4 2021
Q2Q % growth		 409.3M 542.28M-132.98M-24.52%
Q3 2021
Q2Q % growth		 498.9M 456.59M42.31M9.27%
Q2 2021
Q2Q % growth		 343.6M 312.99M30.61M9.78%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -3.5% 0% -15217%
Revenue-0.06% -0.37% -0.19% 0.5%